首页 > 产品目录 > 信号通路 > Angiogenesis > VEGFR > 法瑞西单抗

法瑞西单抗

Anti-Human VEGFAxANGPT2 (Faricimab; RG7716)

产品编号:CLA1508 CAS No.:1607793-29-2 MDLNo: 分子式: 分子量:
规格 库存 目录价 会员专享价 数量

暂无牌价信息,您可以发送询价,我们会尽快给你回复。

化学品安全说明书(MSDS)

下载MSDS
  • 基本信息
  • 相关文档
  • 产品详情
  • 相关文献
基本信息
英文名称 Anti-Human VEGFAxANGPT2 (Faricimab; RG7716)
中文名称法瑞西单抗
CAS号1607793-29-2
储存条件store at -20°C
产品详情

Faricimab is a pioneering humanized bispecific antibody that targets both VEGF-A and Ang-2, offering a dual inhibition approach for retinal diseases like DME and nAMD. By inhibiting VEGF-A, it reduces endothelial cell proliferation and vascular permeability, while blocking Ang-2 is believed to enhance vascular stability and counteract VEGF-A effects. Faricimab has demonstrated a significant reduction in annual injections compared to other anti-VEGF treatments, with a comparable efficacy and safety profile, positioning it as a valuable treatment option for patients with retinal diseases.


相关产品
抱歉,暂时没有相关产品
在线客服
小德
021-58180488
小立
021-58180488
在线服务时间: 工作日 9:00-18:00